Kim, W. R. Et Al. 2015. Impact of Long-Term Tenofovir Disoproxil Fumarate on Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B. CANCER , vol.121, no.20 , 3631-3638.

Kim, W. R., Loomba, R., Berg, T., Schall, R. E. A., Yee, L. J., Dinh, P. V., ... Flaherty, J. F.(2015). Impact of Long-Term Tenofovir Disoproxil Fumarate on Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B. CANCER , vol.121, no.20, 3631-3638.

Kim, W. Et Al. "Impact of Long-Term Tenofovir Disoproxil Fumarate on Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B," CANCER , vol.121, no.20, 3631-3638, 2015

Kim, W. R. Et Al. "Impact of Long-Term Tenofovir Disoproxil Fumarate on Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B." CANCER , vol.121, no.20, pp.3631-3638, 2015

Kim, W. R. Et Al. (2015) . "Impact of Long-Term Tenofovir Disoproxil Fumarate on Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B." CANCER , vol.121, no.20, pp.3631-3638.

@article{article, author={W. Ray Kim Et Al. }, title={Impact of Long-Term Tenofovir Disoproxil Fumarate on Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B}, journal={CANCER}, year=2015, pages={3631-3638} }